{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:03:08Z","timestamp":1785416588541,"version":"3.56.0"},"reference-count":40,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Project of Administration of Traditional Chinese Medicine of Guangdong Province of China","award":["20251263"],"award-info":[{"award-number":["20251263"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background:Recent research has identified pyroptosis as a distinct form of programmed cell death that is strongly correlated with tumor outcomes. However, its value as a prognostic biomarker in clear cell renal cell carcinoma (ccRCC) is not yet fully established.Methods:Differential expression of pyroptosis-related genes between ccRCC and normal tissues was identified using the DESeq2 R package. Next, univariate and least absolute shrinkage and selection operator (LASSO) Cox regression analyses using data from The Cancer Genome Atlas cohort were applied to develop a prognostic model. Univariate and multivariate prognostic analyses were conducted to determine whether the risk score could independently predicted patient prognosis after adjustment for clinicopathological characteristics. A nomogram was then constructed to estimate patient survival probability, supporting clinical decision-making. Expression of pyroptosis-related proteins was assessed using tissue proteomic data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Additionally, the Tumor-Immune System Interaction Database (TISIDB) database was used to analyze immune cell infiltration, whereas gasdermin B (GSDMB) expression in ccRCC cell lines was assessed by Western blot (WB) and quantitative PCR (qPCR) experiments, with immunohistochemistry applied to measure the levels of GSDMB and programmed cell death protein 1 (PD-1).Results:A prognostic risk model was developed using nine genes related to pyroptosis (AIM2, CASP5, GSDMB, GSDMD, NLRP7, NOD2, PYCARD, SCAF11, and NLRP6), employing both univariate Cox and LASSO regression analyses. Based on the median risk score, ccRCC samples were divided into high- and low-risk categories, with Kaplan-Meier analysis revealing poorer survival rates for the high-risk group. Time-dependent receiver operating characteristic curve analysis confirmed the predictive performance of the model for ccRCC prognosis. Furthermore, a nomogram with calibration plots was developed to predict 1-, 3-, and 5-year survival probabilities for patients with ccRCC. Notably, these pyroptosis-related genes were strongly correlated with immune cell infiltration, including cytotoxic cells, CD56bright natural killer cells, and T helper cells. Subsequently, qPCR and WB analyses confirmed elevated GSDMB expression in ccRCC cells, and immunohistochemistry demonstrated a strong correlation between GSDMB and PD-1 expression.Conclusions:Pyroptosis-associated genes, namely AIM2, CASP5, GSDMB, GSDMD, NLRP7, NOD2, PYCARD, SCAF11, and NLRP6, are promising prognostic biomarkers for ccRCC, and may serve as prognostic biomarkers for predicting patient survival and informing immunotherapy strategies.<\/jats:p>","DOI":"10.31083\/fbl51233","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:17:49Z","timestamp":1785413869000},"source":"Crossref","is-referenced-by-count":0,"title":["GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis"],"prefix":"10.31083","volume":"31","author":[{"given":"Guijiao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuerong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"},{"name":"Medical Research Institute, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-6097","authenticated-orcid":true,"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: a Cancer Journal for Clinicians. 2020; 70: 7\u201330.","DOI":"10.3322\/caac.21590"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Vuong L, Kotecha RR, Voss MH, Hakimi AA. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma. Cancer Discovery. 2019; 9: 1349\u20131357.","DOI":"10.1158\/2159-8290.CD-19-0499"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Linehan WM. Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Research. 2012; 22: 2089\u20132100.","DOI":"10.1101\/gr.131110.111"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Bella L, Zona S, Nestal de Moraes G, Lam EWF. FOXM1: A key oncofoetal transcription factor in health and disease. Seminars in Cancer Biology. 2014; 29: 32\u201339.","DOI":"10.1016\/j.semcancer.2014.07.008"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Bedke J, Gauler T, Gr\u00fcnwald V, Hegele A, Herrmann E, Hinz S, et al. Systemic therapy in metastatic renal cell carcinoma. World Journal of Urology. 2017; 35: 179\u2013188.","DOI":"10.1007\/s00345-016-1868-5"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Choueiri TK, Fishman MN, Escudier B, McDermott DF, Drake CG, Kluger H, et al. Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2016; 22: 5461\u20135471.","DOI":"10.1158\/1078-0432.CCR-15-2839"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Loo V, Salgia M, Bergerot P, Philip EJ, Pal SK. First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options. Targeted Oncology. 2019; 14: 639\u2013645.","DOI":"10.1007\/s11523-019-00676-y"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Hofmann F, Hwang EC, Lam TB, Bex A, Yuan Y, Marconi LS, et al. Targeted therapy for metastatic renal cell carcinoma. The Cochrane Database of Systematic Reviews. 2020; 10: CD012796.","DOI":"10.1002\/14651858.CD012796.pub2"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Choueiri TK, Motzer RJ. Systemic Therapy for Metastatic Renal-Cell Carcinoma. The New England Journal of Medicine. 2017; 376: 354\u2013366.","DOI":"10.1056\/NEJMra1601333"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Rizzo A, Mollica V, Santoni M, Ricci AD, Rosellini M, Marchetti A, et al. Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials. European Urology Focus. 2022; 8: 514\u2013521.","DOI":"10.1016\/j.euf.2021.03.001"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nature Reviews. Immunology. 2020; 20: 143\u2013157.","DOI":"10.1038\/s41577-019-0228-2"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Liu X, Lieberman J. A Mechanistic Understanding of Pyroptosis: The Fiery Death Triggered by Invasive Infection. Advances in Immunology. 2017; 135: 81\u2013117.","DOI":"10.1016\/bs.ai.2017.02.002"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015; 526: 660\u2013665.","DOI":"10.1038\/nature15514"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Lin W, Chen Y, Wu B, Chen Y, Li Z. Identification of the pyroptosis\u2011related prognostic gene signature and the associated regulation axis in lung adenocarcinoma. Cell Death Discovery. 2021; 7: 161.","DOI":"10.1038\/s41420-021-00557-2"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Deng M, Sun S, Zhao R, Guan R, Zhang Z, Li S, et al. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Molecular Medicine (Cambridge, Mass.). 2022; 28: 16.","DOI":"10.1186\/s10020-022-00445-0"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Lu X, Chen J, Lu Z, Zang H. Knockdown of PAK1IP1 can Induce Pyroptosis to Inhibit the Progression of Hepatocellular Carcinoma. Frontiers in Bioscience (Landmark Edition). 2025; 30: 26654.","DOI":"10.31083\/fbl26654"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Wu J, Zhu Y, Luo M, Li L. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer. Frontiers in Immunology. 2021; 12: 748221.","DOI":"10.3389\/fimmu.2021.748221"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research. 2003; 13: 2498\u20132504.","DOI":"10.1101\/gr.1239303"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013; 39: 782\u2013795.","DOI":"10.1016\/j.immuni.2013.10.003"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics (Oxford, England). 2019; 35: 4200\u20134202.","DOI":"10.1093\/bioinformatics\/btz210"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Chen X, He WT, Hu L, Li J, Fang Y, Wang X, et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Research. 2016; 26: 1007\u20131020.","DOI":"10.1038\/cr.2016.100"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infection and Immunity. 2005; 73: 1907\u20131916.","DOI":"10.1128\/IAI.73.4.1907-1916.2005"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Huang Y, Zhang Q, Lubas M, Yuan Y, Yalcin F, Efe IE, et al. Synergistic Toll-like Receptor 3\/9 Signaling Affects Properties and Impairs Glioma-Promoting Activity of Microglia. The Journal of Neuroscience : the Official Journal of the Society for Neuroscience. 2020; 40: 6428\u20136443.","DOI":"10.1523\/JNEUROSCI.0666-20.2020"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Ruan J, Wang S, Wang J. Mechanism and regulation of pyroptosis-mediated in cancer cell death. Chemico-biological Interactions. 2020; 323: 109052.","DOI":"10.1016\/j.cbi.2020.109052"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Sarrio D, Colomo S, Moreno-Bueno G. Gasdermin-B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancer. The FEBS journal. 2024; 291: 3060\u20133071.","DOI":"10.1111\/febs.17018"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Yang W, Hu X, Li X. Unveiling the role of gasdermin B in cancer and inflammatory disease: from molecular mechanisms to therapeutic strategies. PeerJ. 2025; 13: e19392.","DOI":"10.7717\/peerj.19392"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Sun L, Wang J, Li Y, Kang Y, Jiang Y, Zhang J, et al. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer. BMC cancer. 2024; 24: 567.","DOI":"10.1186\/s12885-024-12326-2"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Hergueta-Redondo M, Sarri\u00f3 D, Molina-Crespo \u00c1, Megias D, Mota A, Rojo-Sebastian A. Gasdermin-B promotes invasion and metastasis in breast cancer cells. PLoS One. 2014; 9: e90099.","DOI":"10.1371\/journal.pone.0090099"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Molina-Crespo \u00c1, Cadete A, Sarrio D, G\u00e1mez-Chiachio M, Martinez L, Chao K, et al. Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2019; 25: 4846\u20134858.","DOI":"10.1158\/1078-0432.CCR-18-2381"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Saeki N, Usui T, Aoyagi K, Kim DH, Sato M, Mabuchi T, et al. Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium. Genes, Chromosomes & Cancer. 2009; 48: 261\u2013271.","DOI":"10.1002\/gcc.20636"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Chao A, Huang HJ, Lai CH. Human papillomavirus research on the prevention, diagnosis, and prognosis of cervical cancer in Taiwan. Chang Gung Medical Journal. 2012; 35: 297\u2013308.","DOI":"10.4103\/2319-4170.106141"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015; 27: 450\u2013461.","DOI":"10.1016\/j.ccell.2015.03.001"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Fallarino F, Fields PE, Gajewski TF. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. The Journal of Experimental Medicine. 1998; 188: 205\u2013210.","DOI":"10.1084\/jem.188.1.205"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Ross K, Jones RJ. Immune checkpoint inhibitors in renal cell carcinoma. Clinical Science (London, England : 1979). 2017; 131: 2627\u20132642.","DOI":"10.1042\/CS20160894"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Lin W, Zhang Y, Yang Y, Lin B, Zhu M, Xu J, et al. Anti-PD-1\/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2023; 10: e2303908.","DOI":"10.1002\/advs.202303908"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Alishvandi A, Aram C, Shahrivar FF, Kesharwani P, Sahebkar A. Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression. Molecular Cancer. 2025; 24: 297.","DOI":"10.1186\/s12943-025-02506-4"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Chen J, Jiang R, Guan W, Cao Q, Tian Y, Dong K, et al. Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients. International Journal of Medical Sciences. 2024; 21: 496\u2013507.","DOI":"10.7150\/ijms.88301"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Song X, Zhu Y, Geng W, Jiao J, Liu H, Chen R, et al. Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. Journal for Immunotherapy of Cancer. 2025; 13: e010183.","DOI":"10.1136\/jitc-2024-010183"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Fu L, Bao J, Li J, Li Q, Lin H, Zhou Y, et al. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma. Frontiers in Immunology. 2022; 13: 1021935.","DOI":"10.3389\/fimmu.2022.1021935"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Lei K, Chen J, Deng Y, Peng Y, Zhai X, Ren X, et al. Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis. Journal of Experimental & Clinical Cancer Research : CR. 2025; 44: 308.","DOI":"10.1186\/s13046-025-03569-3"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL51233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:19:19Z","timestamp":1785413959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL51233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)03267-0"],"URL":"https:\/\/doi.org\/10.31083\/fbl51233","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"51233"}}